Arp Americas »

Genes shares owned by Arp Americas

Quarter-by-quarter ownership of Genes (GCO) shares owned by Arp Americas from 13F filings

Historical chart of Arp Americas investment in Genes

Tip: Access up to 7 years of quarterly data

All positions including Genes held by Arp Americas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Genes by Arp Americas

Quarter filed Position value Share count Share price at filing
2024-12-31 $543k 13k 42.75
2022-06-30 $692k 14k 49.91

More positions owned by Arp Americas

Merus N V (MRUS)
Potbelly (PBPB)
Steelcase Cl A (SCS)
Norfolk Southern (NSC)
ODP Corp. (ODP)
Veritex Hldgs (VBTX)
Ceridian Hcm Hldg (DAY)
Tourmaline Bio (TRML)
Sandstorm Gold Com New (SAND)
Sapiens Intl Corp N V SHS (SPNS)
Frontier Communications Pare (FYBR)
Chart Industries (GTLS)
Staar Surgical Com Par $0.01 (STAA)
Informatica Com Cl A (INFA)
Performant Finl (PHLT)

View all positions for Arp Americas

Top funds holding Genes

Pzena Investment Management
Fund 1 Investments
BlackRock
Vanguard Group
Dimensional Fund Advisors
Acadian Asset Management
Morgan Stanley
Nomura Holdings
D. E. Shaw & Co
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
State Street Corporation
Geode Capital Management
ING Groep
Healthcare Of Ontario Pension Plan Trust Fund

View all funds holding Genes